文献
J-GLOBAL ID:201802240486682078
整理番号:18A0174736
HER2陽性早期乳癌(EBC)における段階的縮小戦略 WSG-ADAPT HER2+/HR-第II相試験の最終解析 トラスツズマブとペルツズマブでの二重遮断±毎週のパクリタキセルの12週ネオアジュバントの有効性と安全性と予測マーカー
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
著者 (26件):
NITZ U. A.
(West German Study Group GmbH, Moenchengladabach)
,
NITZ U. A.
(Evangelical Hospital Johanniter Bethesda, Moenchengladbach)
,
GLUZ O.
(West German Study Group GmbH, Moenchengladabach)
,
GLUZ O.
(Evangelical Hospital Johanniter Bethesda, Moenchengladbach)
,
GLUZ O.
(Univ. Cologne, Cologne)
,
CHRISTGEN M.
(Medical School Hannover, Hannover)
,
GRISCHKE E.-M.
(Univ. Clinics Tuebingen, Tuebingen)
,
AUGUSTIN D.
(Breast Center Ostbayern, Deggendorf)
,
KUEMMEL S.
(Clinics Essen-Mitte, Essen)
,
BRAUN M.
(Rotkreuz Clinics Munich Breast Center, Munich)
,
POTENBERG J.
(Dep. of Oncology Evangelical Waldkrankenhaus Berlin, Berlin)
,
KOHLS A.
(Evangelical Hospital, Ludwigsfelde)
,
KRAUSS K.
(Univ. Clinics RWTH, Aachen)
,
STEFEK A.
(Evangelical Hospital Johanniter, Stendal)
,
SCHUMACHER C.
(St. Elisabeth Hospital Cologne, Cologne)
,
FORSTBAUER H.
(Oncology Practice Network, Troisdorf)
,
REIMER T.
(Univ. Clinics Rostock, Suedstadt)
,
FISCHER H.
(Evangelical Hospital Gelsenkirchen, Gelsenkirchen)
,
LIEDTKE C.
(Univ. Clinics Schleswig-Holstein, Luebeck)
,
LIEDTKE C.
(Charite Berlin)
,
WUERSTLEIN R.
(Univ. Munich (LMU), Munich)
,
SCHUMACHER J.
(Palleos Healthcare, Wiesbaden, DEU)
,
KATES R.
(West German Study Group GmbH, Moenchengladabach)
,
KREIPE H.
(Univ. Cologne, Cologne)
,
HARBECK N.
(West German Study Group GmbH, Moenchengladabach)
,
HARBECK N.
(Univ. Munich (LMU), Munich)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
28
号:
11
ページ:
2768-2772
発行年:
2017年11月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)